Scope Biosciences B.V. – Trademark Portfolio

Entity Type: 24

Scope Biosciences B.V. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 6 Nice Classification classes. Currently, 0 trademarks are registered and 1 is pending.

Bronland 12 B 1

NL-6708 WH Wageningen

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SCOPEDX
SCOPEDX
Pending 2025

Trademark Classifications

Scope Biosciences B.V.'s trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Scope Biosciences B.V. have?

Scope Biosciences B.V. has 1 U.S. trademark filed with the USPTO. Of these, 1 pending.

What trademark classes does Scope Biosciences B.V. file in?

Scope Biosciences B.V. files trademarks across 6 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.